Should the pharmaceutical manufacturer has several suppliers, then these suppliers should also be assessed by classifying them into different levels centered on their influence on the medicinal merchandise.“It makes it difficult to advise that bringing every one of the API manufacturing back again on the US and Europe solves the issue. It doesn�